Terms: = Germ cell tumor AND QKI, Hqk, 9444, ENSG00000112531, Q96PU8, QK3, DKFZp586I0923, QK
33 results:
1. Case Report: Brainstem angiocentric glioma presenting in a toddler child-diagnostic and therapeutic challenges.
Reisz Z; Radics BL; Nemes P; Laxton R; Kaizer L; Gabor KM; Novak T; Barzo P; Al-Sarraj S; Bodi I
Pathol Oncol Res; 2023; 29():1611231. PubMed ID: 37362245
[No Abstract] [Full Text] [Related]
2. DIPG-like MYB-altered diffuse astrocytoma with durable response to intensive chemotherapy.
Trkova K; Sumerauer D; Krskova L; Vicha A; Koblizek M; Votava T; Priban V; Zapotocky M
Childs Nerv Syst; 2023 Sep; 39(9):2509-2513. PubMed ID: 37165121
[TBL] [Abstract] [Full Text] [Related]
3. Lorlatinib for ALK-fused, infant-type hemispheric glioma with lung metastasis: a case report.
Lai M; Li S; Li H; Hu Q; Li J; Zhou J; Ai R; Zhen J; Zhou Z; Wang L; Zhang Y; Hu W; Yuan L; Ma X; Zhang X; Song C; Li Z; Cai L
Ann Clin Transl Neurol; 2023 May; 10(5):836-841. PubMed ID: 37000961
[TBL] [Abstract] [Full Text] [Related]
4. MYB/MYBL1::qki fusion-positive diffuse glioma.
Suh YY; Lee K; Shim YM; Phi JH; Park CK; Kim SK; Choi SH; Yun H; Park SH
J Neuropathol Exp Neurol; 2023 Feb; 82(3):250-260. PubMed ID: 36592415
[TBL] [Abstract] [Full Text] [Related]
5. Integration of lncRNAs, Protein-Coding Genes and Pathology Images for Detecting Metastatic Melanoma.
Liu S; Fan Y; Li K; Zhang H; Wang X; Ju R; Huang L; Duan M; Zhou F
Genes (Basel); 2022 Oct; 13(10):. PubMed ID: 36292801
[TBL] [Abstract] [Full Text] [Related]
6. Immune landscape of a genetically engineered murine model of glioma compared with human glioma.
Zamler DB; Shingu T; Kahn LM; Huntoon K; Kassab C; Ott M; Tomczak K; Liu J; Li Y; Lai I; Zorilla-Veloz R; Yee C; Rai K; Kim BY; Watowich SS; Heimberger AB; Draetta GF; Hu J
JCI Insight; 2022 Jun; 7(12):. PubMed ID: 35653194
[TBL] [Abstract] [Full Text] [Related]
7. Angiocentric glioma: A case report and review of the literature.
Wang H; Zhu J; Zhu P; Luo C
J Clin Neurosci; 2021 Dec; 94():179-185. PubMed ID: 34863434
[TBL] [Abstract] [Full Text] [Related]
8. Polymorphous Low-Grade Neuroepithelial tumor of the Young (PLNTY): Molecular Profiling Confirms Frequent MAPK Pathway Activation.
Ida CM; Johnson DR; Nair AA; Davila J; Kollmeyer TM; Minn K; Fadra NM; Balcom JR; Fung KA; Kim DK; Kaufmann TJ; Kipp BR; Halling KC; Jenkins RB; Giannini C
J Neuropathol Exp Neurol; 2021 Sep; 80(9):821-829. PubMed ID: 34363682
[TBL] [Abstract] [Full Text] [Related]
9. Ambient carbon monoxide exposure and elevated risk of mortality in the glioblastoma patients: A double-cohort retrospective observational study.
Yoon SJ; Noh J; Son HY; Moon JH; Kim EH; Park SW; Kim SH; Chang JH; Huh YM; Kang SG
Cancer Med; 2020 Dec; 9(23):9018-9026. PubMed ID: 33161654
[TBL] [Abstract] [Full Text] [Related]
10. [Low grade glioma with MYBL1 alteration: Case report of an uncommon pediatric neoplasm].
Appay R; Tauziède-Espariat A; Silva K; Fritih R; Scavarda D; Delteil C; Varlet P; Figarella-Branger D
Ann Pathol; 2021 Feb; 41(1):129-133. PubMed ID: 32732147
[TBL] [Abstract] [Full Text] [Related]
11. MYB-qki rearrangement in angiocentric glioma.
Lian F; Wang LM; Qi XL; Liu LN; Wang XF; Fu J; Xiong J; Lu DH; Piao YS
Clin Neuropathol; 2020; 39(6):263-270. PubMed ID: 32589128
[TBL] [Abstract] [Full Text] [Related]
12. Targeted fusion analysis can aid in the classification and treatment of pediatric glioma, ependymoma, and glioneuronal tumors.
Lake JA; Donson AM; Prince E; Davies KD; Nellan A; Green AL; Mulcahy Levy J; Dorris K; Vibhakar R; Hankinson TC; Foreman NK; Ewalt MD; Kleinschmidt-DeMasters BK; Hoffman LM; Gilani A
Pediatr Blood Cancer; 2020 Jan; 67(1):e28028. PubMed ID: 31595628
[TBL] [Abstract] [Full Text] [Related]
13. qki deficiency maintains glioma stem cell stemness by activating the SHH/GLI1 signaling pathway.
Han B; Wang R; Chen Y; Meng X; Wu P; Li Z; Duan C; Li Q; Li Y; Zhao S; Jiang C; Cai J
Cell Oncol (Dordr); 2019 Dec; 42(6):801-813. PubMed ID: 31292920
[TBL] [Abstract] [Full Text] [Related]
14. Spinal Pleomorphic Xanthoastrocytoma With a qki-RAF1 Fusion.
Daoud EV; Wachsmann M; Richardson TE; Mella D; Pan E; Schwarzbach A; Oliver D; Hatanpaa KJ
J Neuropathol Exp Neurol; 2019 Jan; 78(1):10-14. PubMed ID: 30517658
[TBL] [Abstract] [Full Text] [Related]
15. Somatic genome editing with the RCAS-TVA-CRISPR-Cas9 system for precision tumor modeling.
Oldrini B; Curiel-García Á; Marques C; Matia V; Uluçkan Ö; Graña-Castro O; Torres-Ruiz R; Rodriguez-Perales S; Huse JT; Squatrito M
Nat Commun; 2018 Apr; 9(1):1466. PubMed ID: 29654229
[TBL] [Abstract] [Full Text] [Related]
16. Comprehensive Genomic Profiling of 282 Pediatric Low- and High-Grade Gliomas Reveals Genomic Drivers, tumor Mutational Burden, and Hypermutation Signatures.
Johnson A; Severson E; Gay L; Vergilio JA; Elvin J; Suh J; Daniel S; Covert M; Frampton GM; Hsu S; Lesser GJ; Stogner-Underwood K; Mott RT; Rush SZ; Stanke JJ; Dahiya S; Sun J; Reddy P; Chalmers ZR; Erlich R; Chudnovsky Y; Fabrizio D; Schrock AB; Ali S; Miller V; Stephens PJ; Ross J; Crawford JR; Ramkissoon SH
Oncologist; 2017 Dec; 22(12):1478-1490. PubMed ID: 28912153
[TBL] [Abstract] [Full Text] [Related]
17. CRAF gene fusions in pediatric low-grade gliomas define a distinct drug response based on dimerization profiles.
Jain P; Fierst TM; Han HJ; Smith TE; Vakil A; Storm PB; Resnick AC; Waanders AJ
Oncogene; 2017 Nov; 36(45):6348-6358. PubMed ID: 28806393
[TBL] [Abstract] [Full Text] [Related]
18. Copy number alterations determined by single nucleotide polymorphism array testing in the clinical laboratory are indicative of gene fusions in pediatric cancer patients.
Busse TM; Roth JJ; Wilmoth D; Wainwright L; Tooke L; Biegel JA
Genes Chromosomes Cancer; 2017 Oct; 56(10):730-749. PubMed ID: 28597942
[TBL] [Abstract] [Full Text] [Related]
19. Overexpression of miR-29a reduces the oncogenic properties of glioblastoma stem cells by downregulating Quaking gene isoform 6.
Xi Z; Wang P; Xue Y; Shang C; Liu X; Ma J; Li Z; Li Z; Bao M; Liu Y
Oncotarget; 2017 Apr; 8(15):24949-24963. PubMed ID: 28212562
[TBL] [Abstract] [Full Text] [Related]
20. Tyrosine receptor kinase B is a drug target in astrocytomas.
Ni J; Xie S; Ramkissoon SH; Luu V; Sun Y; Bandopadhayay P; Beroukhim R; Roberts TM; Stiles CD; Segal RA; Ligon KL; Hahn WC; Zhao JJ
Neuro Oncol; 2017 Jan; 19(1):22-30. PubMed ID: 27402815
[TBL] [Abstract] [Full Text] [Related]
[Next]
